Breaking News Instant updates and real-time market news.

F

Ford

$9.50

0.04 (0.42%)

, GM

General Motors

$36.20

0.06 (0.17%)

05:44
08/15/18
08/15
05:44
08/15/18
05:44

Turkey doubles tariffs on U.S. imports, including cars, alcohol, Reuters reports

Turkey has doubled tariffs on some U.S. imports, such as cars, alcohol and tobacco, in what its vice president said was a response to deliberate U.S. attacks on the Turkish economy, Reuters reports. A decree signed by President Tayyip Erdogan, doubled Turkish tariffs on passenger cars to 120%, on alcoholic drinks to 140% and on leaf tobacco to 60%, Tariffs were also doubled on goods such as cosmetics, rice and coal in retaliation for U.S. moves. Last Friday, U.S. President Donald Trump said he had authorized higher tariffs on aluminum and steel imports from Turkey. Reference Link

F

Ford

$9.50

0.04 (0.42%)

GM

General Motors

$36.20

0.06 (0.17%)

FCAU

Fiat Chrysler

$15.97

-0.13 (-0.81%)

X

U.S. Steel

$29.98

-0.225 (-0.74%)

CENX

Century Aluminum

$12.47

0.395 (3.27%)

AA

Alcoa

$44.11

-0.355 (-0.80%)

AKS

AK Steel

$4.17

-0.09 (-2.11%)

  • 15

    Aug

  • 15

    Aug

  • 31

    Aug

  • 11

    Sep

F Ford
$9.50

0.04 (0.42%)

08/14/18
NOMU
08/14/18
NO CHANGE
Target $9
NOMU
Neutral
Ford price target lowered to $9 from $10 at Nomura Instinet
Nomura Instinet analyst Anindya Das lowered his price target for Ford to $9 after reducing fiscal 2018 earnings per share estimate by 17% to $1.20. The analyst lowered his outlook for Ford's Asia Pacific operations based on first half of 2018 sales trends and also sees Europe becoming more difficult. Das keeps a Neutral rating on Ford shares.
07/20/18
JPMS
07/20/18
NO CHANGE
JPMS
Overweight
JPMorgan says buy GM, sell Tesla into Q2 earnings reports
JPMorgan analyst Ryan Brinkman forecasts lower than consensus Q2 earnings for Ford (F) and higher than Street earnings for General Motors (GM). Both companies are likely to be impacted by higher commodity costs during the quarter, although the decline in spot prices subsequent to the quarter should limit impact to the full year, Brinkman tells investors in a research note previewing the Q2 earnings for the automakers. The analyst is also concerned about the potential for a "large loss and accompanying large cash outflow" at Tesla in Q2 to "make the bridge" to GAAP profitability and positive cash generation in the second half of the year. Brinkman maintains Overweight ratings on GM and Ford, with a preference for GM shares. He also keeps his cautious Underweight rating on Tesla shares, seeing 44% downside to his $180 December 2018 price target.
07/20/18
07/20/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS YUM CHINA TO UNDERPERFORM: BofA Merrill Lynch analyst Chen Luo downgraded Yum China (YUMC) to Underperform from Neutral and cut its price target to $34 from $44.30. Luo said he expects Yum China to continue to underperform given a likely peak in KFC trends amid China's weakening macro environment, a likely prolonged turnaround at Pizza Hut combined with heavy costs, a slowdown in Chinese consumer consumption, and RMB depreciation. Yum China is down 4.8% in late morning trading. CREDIT SUISSE CUTS FIVE BELOW TO NEUTRAL: Credit Suisse analyst Judah Frommer downgraded Five Below (FIVE) to Neutral from Outperform, telling investors that he is moving to the sidelines as he sees risk/reward balanced at current levels given the stock's material outperformance and back-half comp acceleration that he believes is priced into shares. Frommer keeps his $110 price target and says Five Below remains one of the most differentiated concepts in retail. Five Below is down 4.4% in late morning trading. BAIRD MORE CAUTIOUS ON DRUG SUPPLY CHAIN: Baird analyst Eric Coldwell downgraded Express Scripts (ESRX), AmerisourceBergen (ABC), and McKesson (MCK), all to Neutral from Outperform, citing the heavy political attack in recent weeks against pharmacy benefit managers and members of the drug supply chain. Among them, he said AmerisourceBergen remains his preferred name, but he cannot justify putting new money to work in these names in the current environment. SUNTRUST STARTS VIKING WITH A BUY: SunTrust analyst Edward Nash initiated Viking Therapeutics (VKTX) with a Buy rating and a price target of $14, saying its VK2809 drug for lipid disorders "has the potential to become a promising treatment by addressing multiple metabolic issues" associated with the non-alcoholic steatohepatitis disease, or NASH. Viking is up 8.3% in late morning trading. JPMORGAN SAYS BUY GM, SELL TESLA INTO EARNINGS: JPMorgan analyst Ryan Brinkman forecast lower than consensus Q2 earnings for Ford (F) and higher than consensus earnings for General Motors (GM). The analyst is also concerned about the potential for a "large loss and accompanying large cash outflow" at Tesla (TSLA) in Q2 to "make the bridge" to GAAP profitability and positive cash generation in the second half of the year. Brinkman maintained Overweight ratings on GM and Ford, with a preference for GM shares. He also kept his cautious Underweight rating on Tesla shares, seeing 44% downside to his $180 December 2018 price target.
07/24/18
PIPR
07/24/18
NO CHANGE
Target $57
PIPR
Overweight
General Motors outperforming Ford in China, says Piper Jaffray
While both would suffer in a trade war, it is clear that General Motors (GM) is outperforming Ford (F) in China, Piper Jaffray analyst Alexander Potter tells investors in a research note. The analyst views GM's China business as stable, with a growing presence in luxury. He thinks Cadillac represented 16.7% of GM's Q2 revenue in China, versus 13.6% in 2017, which should boost margins. Until its "new product blitz gains momentum, Ford's China business will likely continue bleeding," Potter contends. He notes the company's Ford's retail sales in China declined by 38% year-over-year in June. The analyst keeps an Overweight rating on GM and a Neutral rating on Ford.
GM General Motors
$36.20

0.06 (0.17%)

07/26/18
SBSH
07/26/18
NO CHANGE
Target $60
SBSH
Buy
General Motors price target lowered to $60 from $70 at Citi
Citi analyst Itay Michaeli lowered his price target for General Motors to $60 citing worse currency and commodity headwinds following yesterday's Q2 results. The analyst keeps a Buy rating on the shares. GM's guidance, while disappointing, doesn't signal a change to the core thesis around pickup truck and robotaxi networks, Michaeli tells investors in a research note.
FCAU Fiat Chrysler
$15.97

-0.13 (-0.81%)

07/17/18
JEFF
07/17/18
NO CHANGE
Target $25
JEFF
Buy
Santander Consumer, Fiat Chrysler tolling agreement doesn't change much, says Jefferies
Jefferies analyst John Hecht notes that Santander Consumer (SC) and Fiat Chrysler (FCAU) entered a tolling agreement that allows both parties additional time to assess their rights, obligations, claims, etc. while not having to worry about the statute of limitations. The analyst believes the tolling agreement does not change much of what is going on. Nonetheless, Hecht notes that the companies also acknowledged they are working to resolve the matter tied to the captive finance, with the agreement indicating that a resolution on this matter may come in months rather than quarters. He reiterates a Buy rating and $25 price target on Santander Consumer shares.
07/10/18
UBSW
07/10/18
UPGRADE
UBSW
Buy
UBS upgrades Fiat Chrysler to Buy ahead of Q2 results
UBS analyst Patrick Hummel upgraded Fiat Chrysler (FCAU) to Buy from Neutral with a price target of EUR 23. The analyst expects the company's "positive volume/mix impact story" to continue in Q2 even with the ramp of the new RAM 1500 truck unlikely to be completed until Q3. Fiat shares should deliver the best earnings momentum among the European car manufacturers in the coming quarters, Hummel tells investors in a research note.
07/10/18
UBSW
07/10/18
UPGRADE
UBSW
Buy
Fiat Chrysler upgraded to Buy from Neutral at UBS
UBS analyst Patrick Hummel upgraded Fiat Chrysler to Buy.
08/07/18
MSCO
08/07/18
NO CHANGE
Target $1325
MSCO
Overweight
Enterprise value of Alphabet's Waymo raised to $175B at Morgan Stanley
Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, namely logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Partnerships with Walmart (WMT), DDR (DDR) and Peterbilt speak to Waymo's logistics focus, said Nowak, who sees the company potentially having a $90B logistics business. Additionally, he sees a roughly $7B licensing opportunity, pointing to the company's FCA (FCAU) relationship as a model of how companies could pay a license fee to Waymo for its autonomous technology. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares.
X U.S. Steel
$29.98

-0.225 (-0.74%)

04/30/18
JPMS
04/30/18
NO CHANGE
Target $67
JPMS
Overweight
U.S. Steel shares oversold at current levels, says JPMorgan
JPMorgan analyst Michael Gambardella calls U.S. Steel "another oversold buying opportunity." The analyst thinks investors should focus on the company's "strong earnings power" in the second half of 2018 implied by its EBITDA guidance. Market conditions will continue to remain supportive for steel prices in the second half and 2019 with the President's actions on Section 232 and trade related matters, Gambardella tells investors in a research note. He lowered his price target for the shares to $67 from $69 and reiterates an Overweight rating on U.S. Steel.
04/30/18
BMOC
04/30/18
NO CHANGE
Target $45
BMOC
Market Perform
U.S. Steel price target lowered to $45 from 50 at BMO Capital
BMO Capital analyst David Gagliano lowered his price target on U.S. Steel to $45, saying that despite the "inexpensive" valuation of the sector amid the persisting high steel prices, the company is faced with execution risk within its 3-year "revitalization program". Gagliano keeps his Market Perform rating on U.S. Steel, adding that steel investors are typically sensitive to volatility and calling for greater visibility and execution to justify a more constructive view.
04/30/18
LBOW
04/30/18
NO CHANGE
Target $49
LBOW
Buy
U.S. Steel price target lowered to $49 from $63 at Longbow
Longbow analyst Chris Olin lowered his price target on U.S. Steel to $49 from $63 due to using a more conservative multiple, though he noted that management expects much higher price realizations in the second half and he sees it being set up well for a strong performance in the back half of the year. Olin maintains a Buy rating on U.S. Steel shares.
04/30/18
SBSH
04/30/18
NO CHANGE
Target $42
SBSH
Buy
U.S. Steel selloff Friday a 'significant overreaction,' says Citi
Citi analyst Alexander Hacking says the 14% selloff in shares of U.S. Steel on Friday seems like a "significant overreaction" to the "poor" Q2 guidance. The analyst expects a "significant uplift in profits" in the second half of 2018 as current pricing flows through. His bull thesis on the shares is unchanged but he lowered his price target for Buy-rated U.S. Steel to $42 from $46.
CENX Century Aluminum
$12.47

0.395 (3.27%)

05/04/18
JPMS
05/04/18
DOWNGRADE
Target $21
JPMS
Neutral
Century Aluminum downgraded on higher alumina costs at JPMorgan
JPMorgan analyst Michael Gambardella downgraded Century Aluminum to Neutral from Overweight and lowered his price target for the shares to $21 from $29. The downgrade reflects the analyst's estimates for higher alumina costs and modestly lower Midwest premium. While Section 232 will likely result in a higher Midwest premium over the near to medium term, potential alumina shortages from the Alunorte refinery outage and the uncertainty surrounding U.S. sanctions on Russia could cause alumina prices to remain elevated for a period of time, Gambardella tells investors in a research note.
06/20/18
RILY
06/20/18
INITIATION
Target $27
RILY
Buy
Century Aluminum initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Lucas Pipes started Century Aluminum with a Buy rating and $27 price target.
06/21/18
06/21/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alcoa (AA) initiated with a Neutral at B. Riley FBR while Century Aluminum (CENX) was initiated with a Buy. 2. Westlake Chemical (WLK) initiated with an Outperform at Bernstein while Westlake Chemical Partners (WLKP) was initiated with a Market Perform. 3. RealPage (RP) initiated with an Overweight at JPMorgan. 4. JBG Smith Properties (JBGS) initiated with a Sell at Stifel. 5. Kimberly-Clark (KMB) initiated with an Underweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/02/18
DBAB
08/02/18
UPGRADE
Target $20
DBAB
Buy
Century Aluminum upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Jeremy Kliewer upgraded Century Aluminum to Buy with an unchanged price target of $20. The analyst cites the company's Q2 results and upcoming production enhancements for the upgrade.
AA Alcoa
$44.11

-0.355 (-0.80%)

07/19/18
JEFF
07/19/18
NO CHANGE
Target $65
JEFF
Buy
Alcoa shares look undervalued despite guidance cut, says Jefferies
Jefferies analyst Christopher LaFemina says Alcoa's guidance cut on lower commodity prices, higher energy costs and U.S. tariffs offset the company's "solid" Q2 results. Alcoa continues to reduce its pension liability and is positioned to return cash to shareholders in the second half of 2018, LaFemina tells investors in a research note. He recommends buying the stock on the post-earnings weakness and keeps a Buy rating on Alcoa with a $65 price target. The analyst thinks the shares look undervalued at current levels.
07/19/18
BMOC
07/19/18
NO CHANGE
Target $75
BMOC
Outperform
Alcoa price target lowered to $75 from $80 at BMO Capital
BMO Capital analyst David Gagliano lowered his price target on Alcoa to $75 after its Q2 results, saying its adjusted EBITDA missed expectations in Q2 and the company also reduced the FY18 EBITDA guidance to reflect higher input costs. The analyst also kept his Outperform rating, noting that despite the lowered outlook, shares still trade at "only" 3.6-times his expected FY19 EBITDA on alumina/aluminum prices that are near global marginal cost. Gagliano adds that global deficit conditions in aluminum are still likely.
07/23/18
MSCO
07/23/18
NO CHANGE
Target $57
MSCO
Overweight
Alcoa post-earnings selloff presents attractive entry point, says Morgan Stanley
Morgan Stanley analyst Piyush Sood remains constructive on Alcoa as he believes aluminum and alumina prices be supported by China's winter cuts, operations should improve on lower maintenance headwinds and smelter restarts and he thinks the company will initiate a dividend within about 3 months. He sees last week's roughly 20% selloff as investors reacted to the Q2 EBITDA miss and larger than expected FY18 guidance cut as an opportunity to buy shares at an attractive entry point, Sood tells investors. He lowered his price target to $57 from $60 to factor in updated guidance but maintains an Overweight rating on Alcoa shares.
07/24/18
DBAB
07/24/18
NO CHANGE
Target $55
DBAB
Buy
Alcoa screens as inexpensive after selloff, says Deutsche Bank
Deutsche Bank analyst Chris Terry says that following the 16% decline in the past two days after earnings, shares of Alcoa screen as inexpensive. The analyst lowered his price target to $55 from $70 to reflect the weaker than expected Q2 results. He maintains a Buy rating on Alcoa, however, with 36% upside potential.
AKS AK Steel
$4.17

-0.09 (-2.11%)

05/30/18
05/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Hold from Buy at Maxim with analyst Nehal Chokshi saying he sees high risk that FY19 will be a "down year" given declines in the broader smartphone market. 2. AK Steel (AKS) downgraded to Sell from Neutral at Goldman Sachs with analyst Matthew Korn citing continued underperformance by the company in terms of pricing and margins and also points to its limited visibility around downstream operations. 3. AbbVie (ABBV) downgraded to Underperform from Neutral at Credit Suisse with analyst Vamil Divan saying he is increasingly concerned about the longevity of its flagship product Humira. 4. Petrobras (PBR) downgraded to Hold from Buy at Santander. 5. Hope Bancorp (HOPE) downgraded to Neutral from Buy at DA Davidson with analyst Gary Tenner saying that while the company has posted "solid profitability metrics," its 100% loan/deposit ratio will make it challenging to fund growth without hurting net interest margins. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
DBAB
07/09/18
DOWNGRADE
Target $5
DBAB
Hold
AK Steel downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Chris Terry downgraded AK Steel to Hold and lowered his price target for the shares to $5 from $6. The analyst believes the steel sector is underappreciated but moderated his positive view on the Steel & Service Center space. He is "not of the view that the cycle will be sustainable" and continues to prefer mini-mills over integrated.
07/09/18
DBAB
07/09/18
DOWNGRADE
Target $12
DBAB
Hold
Ryerson downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Chris Terry downgraded Ryerson to Hold and lowered his price target for the shares to $12 from $13. The analyst believes the steel sector is underappreciated but moderated his positive view on the Steel & Service Center space. He is "not of the view that the cycle will be sustainable" and continues to prefer mini-mills over integrated. Terry this morning also downgraded AK Steel (AKS) to Hold.
05/29/18
GSCO
05/29/18
DOWNGRADE
Target $4
GSCO
Sell
AK Steel downgraded to Sell at Goldman Sachs on disappointing margins, pricing
As reported earlier, Goldman Sachs analyst Matthew Korn downgraded AK Steel to Sell from Neutral and lowered his price target to $4 from $6. The analyst cites continued underperformance by the company in terms of pricing and margins and also points to its limited visibility around downstream operations. Korn adds that AK Steel carries some additional downside valuation potential relative to his other stocks in the steel sector.

TODAY'S FREE FLY STORIES

KORS

Michael Kors

$66.71

-5.96 (-8.20%)

06:48
09/25/18
09/25
06:48
09/25/18
06:48
Hot Stocks
Breaking Hot Stocks news story on Michael Kors »

Michael Kors trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$139.30

-2.62 (-1.85%)

06:47
09/25/18
09/25
06:47
09/25/18
06:47
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SFIX

Stitch Fix

$41.31

0.93 (2.30%)

06:46
09/25/18
09/25
06:46
09/25/18
06:46
Recommendations
Stitch Fix analyst commentary  »

Stitch Fix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 04

    Oct

  • 13

    Nov

XOXO

XO Group

$27.62

-0.26 (-0.93%)

06:45
09/25/18
09/25
06:45
09/25/18
06:45
Hot Stocks
Breaking Hot Stocks news story on XO Group »

XO Group trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOLD

Randgold

$68.12

4.18 (6.54%)

, ABX

Barrick Gold

$11.03

0.55 (5.25%)

06:42
09/25/18
09/25
06:42
09/25/18
06:42
Downgrade
Randgold, Barrick Gold rating change  »

Randgold downgraded to…

GOLD

Randgold

$68.12

4.18 (6.54%)

ABX

Barrick Gold

$11.03

0.55 (5.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NVS

Novartis

$85.28

-0.18 (-0.21%)

06:41
09/25/18
09/25
06:41
09/25/18
06:41
Periodicals
Novartis cuts jobs in UK, Switzerland, FT reports »

Novartis has decided to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

FB

Facebook

$165.40

2.5 (1.53%)

, GOOG

Alphabet

$1,173.38

7.17 (0.61%)

06:40
09/25/18
09/25
06:40
09/25/18
06:40
Periodicals
Report says technology giants deserve tougher regulation, WSJ reports »

Technology giants cannot…

FB

Facebook

$165.40

2.5 (1.53%)

GOOG

Alphabet

$1,173.38

7.17 (0.61%)

GOOGL

Alphabet Class A

$1,179.78

7.56 (0.64%)

AMZN

Amazon.com

$1,934.50

16.75 (0.87%)

TWTR

Twitter

$28.59

0.09 (0.32%)

AAPL

Apple

$220.79

3.14 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

EUXTF

Euronext

$0.00

(0.00%)

06:40
09/25/18
09/25
06:40
09/25/18
06:40
Upgrade
Euronext rating change  »

Euronext upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYGN

Myriad Genetics

$46.91

0.64 (1.38%)

06:39
09/25/18
09/25
06:39
09/25/18
06:39
Conference/Events
Myriad Genetics management to meet with Stephens »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

MOGO

Mogo Finance

$3.04

-0.09 (-2.88%)

06:38
09/25/18
09/25
06:38
09/25/18
06:38
Conference/Events
Mogo Finance management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

HMNY

Helios and Matheson

$0.02

0.0038 (27.34%)

06:38
09/25/18
09/25
06:38
09/25/18
06:38
Periodicals
MoviePass picks former Rotten Tomatoes EIC to head Moviefone, Page Six says »

MoviePass, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$265.72

2.28 (0.87%)

06:37
09/25/18
09/25
06:37
09/25/18
06:37
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 10

    Dec

GG

Goldcorp

$10.64

0.03 (0.28%)

06:36
09/25/18
09/25
06:36
09/25/18
06:36
Downgrade
Goldcorp rating change  »

Goldcorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SIRI

Sirius XM

$6.25

-0.72 (-10.33%)

, P

Pandora

$8.98

-0.1 (-1.10%)

06:35
09/25/18
09/25
06:35
09/25/18
06:35
Downgrade
Sirius XM, Pandora rating change  »

Sirius XM downgraded to…

SIRI

Sirius XM

$6.25

-0.72 (-10.33%)

P

Pandora

$8.98

-0.1 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

WTI

W&T Offshore

$8.09

0.37 (4.79%)

06:35
09/25/18
09/25
06:35
09/25/18
06:35
Hot Stocks
W&T Offshore to sell overriding royalty interests in Permian Basin for $56.8M »

W&T Offshore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTH

LightPath

$2.01

-0.04 (-1.95%)

06:35
09/25/18
09/25
06:35
09/25/18
06:35
Conference/Events
LightPath management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NICE

Nice Systems

$113.27

0.16 (0.14%)

06:33
09/25/18
09/25
06:33
09/25/18
06:33
Hot Stocks
Nice Systems implements RPS solution for SBI Card »

NICE announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$165.40

2.5 (1.53%)

06:32
09/25/18
09/25
06:32
09/25/18
06:32
Periodicals
Content moderater sues Facebook, says job gave her PTSD, Vice reports »

Selena Scola, a former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

TFX

Teleflex

$268.91

-0.84 (-0.31%)

06:32
09/25/18
09/25
06:32
09/25/18
06:32
Hot Stocks
Teleflex subsiidiary presents new clinical data from studies of UroLift System »

NeoTract, a wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

  • 08

    Nov

CNI

Canadian National

$86.82

-1.86 (-2.10%)

06:32
09/25/18
09/25
06:32
09/25/18
06:32
Upgrade
Canadian National rating change  »

Canadian National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

CERC

Cerecor

$4.56

0.17 (3.87%)

06:31
09/25/18
09/25
06:31
09/25/18
06:31
Hot Stocks
Cerecor to acquire Ichorion Therapeutics in $26.6M transaction »

Cerecor announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ABX

Barrick Gold

$11.03

0.55 (5.25%)

, GOLD

Randgold

$68.12

4.18 (6.54%)

06:31
09/25/18
09/25
06:31
09/25/18
06:31
Upgrade
Barrick Gold, Randgold rating change  »

Barrick Gold upgraded to…

ABX

Barrick Gold

$11.03

0.55 (5.25%)

GOLD

Randgold

$68.12

4.18 (6.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

KIDS

OrthoPediatrics

$33.52

0.69 (2.10%)

06:29
09/25/18
09/25
06:29
09/25/18
06:29
Conference/Events
OrthoPediatrics management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Nov

JLL

Jones Lang LaSalle

$146.77

1.4 (0.96%)

06:28
09/25/18
09/25
06:28
09/25/18
06:28
Conference/Events
Jones Lang LaSalle management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

NRE

Northstar Realty Europe

$12.87

0.14 (1.10%)

, CLNY

Colony Capital

$6.15

-0.04 (-0.65%)

06:28
09/25/18
09/25
06:28
09/25/18
06:28
Hot Stocks
Senvest Management sends letter to Northstar Realty Europe board »

Senvest Management, an…

NRE

Northstar Realty Europe

$12.87

0.14 (1.10%)

CLNY

Colony Capital

$6.15

-0.04 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.